Literature DB >> 7631596

Prediction of acute coronary syndromes by percutaneous coronary angioscopy in patients with stable angina.

Y Uchida1, F Nakamura, T Tomaru, T Morita, T Oshima, T Sasaki, S Morizuki, J Hirose.   

Abstract

To pinpoint the link between plaque characteristics and acute coronary syndromes, we performed a 12-month prospective follow-up study in 157 patients with stable angina pectoris in whom regular coronary plaques were observed by percutaneous coronary angioscopy. Acute coronary syndromes occurred more frequently in patients with yellow plaque than in those with white plaques (11 of 39 vs 4 of 118; p = 0.00021). Moreover, the syndromes occurred more frequently in patients with glistening yellow plaques than in those with nonglistening yellow plaques (9 of 13 vs 2 of 26; p = 0.00026). Thrombus arising from the ruptured identical plaques was confirmed by angioscopy as the culprit lesion of the syndromes. The results indicate that acute coronary syndromes occur frequently and in a short time in patients with glistening yellow plaques and that angioscopy but not angiography is feasible for prediction of the syndromes.

Entities:  

Mesh:

Year:  1995        PMID: 7631596     DOI: 10.1016/0002-8703(95)90429-8

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  22 in total

Review 1.  New developments in the detection of vulnerable plaque.

Authors:  M Naghavi; M Madjid; M R Khan; R M Mohammadi; J T Willerson; S W Casscells
Journal:  Curr Atheroscler Rep       Date:  2001-03       Impact factor: 5.113

2.  Two-dimensional visualization of cholesterol and cholesteryl esters within human coronary plaques by near-infrared fluorescence angioscopy.

Authors:  Yasumi Uchida; Yasuto Uchida; Yukou Sugiyama; Takanobu Tomaru; Seiji Kawai; Ryohei Kanamaru; Ei Shimoyama
Journal:  Clin Cardiol       Date:  2010-12       Impact factor: 2.882

3.  Angioscopic observation during carotid angioplasty with stent placement.

Authors:  Hiroshi Tanemura; Seiji Hatazaki; Fumio Asakura; Kenji Kawaguchi; Keita Kuraishi; Naoki Toma; Hiroshi Sakaida; Masayuki Maeda; Waro Taki
Journal:  AJNR Am J Neuroradiol       Date:  2005-09       Impact factor: 3.825

Review 4.  Optical coherence tomography for imaging the vulnerable plaque.

Authors:  Guillermo J Tearney; Ik-Kyung Jang; Brett E Bouma
Journal:  J Biomed Opt       Date:  2006 Mar-Apr       Impact factor: 3.170

Review 5.  Spectroscopy to improve identification of vulnerable plaques in cardiovascular disease.

Authors:  Janneke L M Bruggink; Robbert Meerwaldt; Gooitzen M van Dam; Joop D Lefrandt; Riemer H J A Slart; René A Tio; Andries J Smit; Clark J Zeebregts
Journal:  Int J Cardiovasc Imaging       Date:  2009-09-17       Impact factor: 2.357

6.  Intravascular optical coherence tomography [Invited].

Authors:  Brett E Bouma; Martin Villiger; Kenichiro Otsuka; Wang-Yuhl Oh
Journal:  Biomed Opt Express       Date:  2017-04-26       Impact factor: 3.732

Review 7.  Imaging of vulnerable plaques using near-infrared spectroscopy for risk stratification of atherosclerosis.

Authors:  Saurabh Sanon; Tim Dao; Vani P Sanon; Robert Chilton
Journal:  Curr Atheroscler Rep       Date:  2013-02       Impact factor: 5.113

8.  Unstable or High Risk Plaque: How Do We Approach It?

Authors:  A B Mehta; Sameer Shah
Journal:  Med J Armed Forces India       Date:  2011-07-21

9.  A higher colour grade yellow plaque was detected at one year after implantation of an everolimus-eluting stent than after a zotarolimus-eluting stent.

Authors:  Koshi Matsuo; Yasunori Ueda; Mayu Nishio; Akio Hirata; Mitsutoshi Asai; Takayoshi Nemoto; Ayaka Murakami; Kazunori Kashiwase; Kazuhisa Kodama
Journal:  Heart Asia       Date:  2013-09-07

Review 10.  Molecular imaging in atherosclerosis.

Authors:  Andor W J M Glaudemans; Riemer H J A Slart; Alessandro Bozzao; Elena Bonanno; Marcello Arca; Rudi A J O Dierckx; Alberto Signore
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-03-20       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.